Back
Trinity Industries 10K Form
Buy
55
TRN
Trinity Industries
Last Price:
$35.17
Seasonality Move:
6.2%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-02 | 10Q | TRN/Trinity Industries Quarterly |
2023-08-01 | 10Q | TRN/Trinity Industries Quarterly |
2023-05-02 | 10Q | TRN/Trinity Industries Quarterly |
2022-10-25 | 10Q | TRN/Trinity Industries Quarterly |
2022-07-27 | 10Q | TRN/Trinity Industries Quarterly |
2022-04-27 | 10Q | TRN/Trinity Industries Quarterly |
Receive TRN News And Ratings
See the #1 stock for the next 7 days that we like better than TRN
TRN Financial Statistics
Sales & Book Value
Annual Sales: | $3B |
---|---|
Cash Flow: | $-45.4M |
Price / Cash Flow: | 0 |
Annual Sales: | $12.83 |
Price / Book: | 2.78 |
Profitability
EPS (TTM): | 2.05000 |
---|---|
Net Income (TTM): | $172.3M |
Gross Margin: | $527.1M |
Return on Equity: | 13.42% |
Return on Assets: | 1.93% |
Trinity Industries Earnings Forecast
Key Trinity Industries Financial Ratios
-
The Gross Profit Margin over the past 40 years for TRN is 17.67%.
-
The Selling, General & Administrative Expenses for TRN have been equal to 6.77% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 250.47% of Operating Income.
-
The Net Earning history of TRN is 3.55% of Total Revenues.
-
Per Share Earnings over the last 40 years have been positive in 24 years.
Trinity Industries Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Machinery |
Sector: | Industrials |
Current Symbol: | TRN |
CUSIP: | 896522 |
Website: | trin.net |
Debt
Debt-to-Equity Ratio: | 5.39 |
---|---|
Current Ratio: | 2.18 |
Quick Ratio: | 1.08 |
Price-to-Earnings
Trailing P/E Ratio: | 28.16 |
---|---|
Forward P/E Ratio: | 21.04 |
TRN Technical Analysis vs Fundamental Analysis
Buy
55
Trinity Industries (TRN)
is a Buy
Is Trinity Industries a Buy or a Sell?
-
Trinity Industries stock is rated a BuyThe current Trinity Industries [TRN] share price is $35.76. The Score for TRN is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.